115 related articles for article (PubMed ID: 18707937)
1. [Bipolar disorder and somatic comorbidity].
Corruble E
Encephale; 2008 Jun; 34 Suppl 4():S143-5. PubMed ID: 18707937
[No Abstract] [Full Text] [Related]
2. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
3. Obesity and metabolic syndrome in a psychiatric rehabilitation service.
Tirupati S; Chua LE
Aust N Z J Psychiatry; 2007 Jul; 41(7):606-10. PubMed ID: 17558623
[TBL] [Abstract][Full Text] [Related]
4. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
5. Treatment of bipolar disorders and metabolic syndrome: implications for primary care.
Bell PF; McKenna JP; Roscoe BM
Postgrad Med; 2009 Sep; 121(5):140-4. PubMed ID: 19820282
[TBL] [Abstract][Full Text] [Related]
6. Side effects as influencers of treatment outcome.
Sharif Z
J Clin Psychiatry; 2008; 69 Suppl 3():38-43. PubMed ID: 18533761
[TBL] [Abstract][Full Text] [Related]
7. Bipolar disorder and metabolic syndrome: comorbidity or side effects of treatment of bipolar disorder.
Babić D; Maslov B; Martinac M; Nikolić K; Uzun S; Kozumplik O
Psychiatr Danub; 2010 Mar; 22(1):75-8. PubMed ID: 20305595
[TBL] [Abstract][Full Text] [Related]
8. Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions.
Megna JL; Schwartz TL; Siddiqui UA; Herrera Rojas M
Ann Clin Psychiatry; 2011 May; 23(2):131-40. PubMed ID: 21547274
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease and bipolar disorder: risk and clinical implications.
Swartz HA; Fagiolini A
J Clin Psychiatry; 2012 Dec; 73(12):1563-5. PubMed ID: 23290329
[No Abstract] [Full Text] [Related]
10. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome - the consequence of lifelong treatment of bipolar affective disorder.
Dadić-Hero E; Ruzić K; Grahovac T; Petranović D; Graovac M; Palijan TZ
Psychiatr Danub; 2010 Jun; 22(2):381-4. PubMed ID: 20562789
[TBL] [Abstract][Full Text] [Related]
12. Life events, medical comorbidity, and somatic symptoms in pediatric mood disorders.
Wagner KD
J Clin Psychiatry; 2009 Oct; 70(10):1439-40. PubMed ID: 19906347
[No Abstract] [Full Text] [Related]
13. Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort.
Godin O; Etain B; Henry C; Bougerol T; Courtet P; Mayliss L; Passerieux C; Azorin JM; Kahn JP; Gard S; Costagliola D; Leboyer M;
J Clin Psychiatry; 2014 Oct; 75(10):1078-85; quiz 1085. PubMed ID: 25373115
[TBL] [Abstract][Full Text] [Related]
14. Recognizing parents' symptoms, obesity, and bipolar depression.
Wagner KD
J Clin Psychiatry; 2008 Dec; 69(12):1937. PubMed ID: 19203477
[No Abstract] [Full Text] [Related]
15. Medical comorbidity in bipolar disorder: re-prioritizing unmet needs.
McIntyre RS; Soczynska JK; Beyer JL; Woldeyohannes HO; Law CW; Miranda A; Konarski JZ; Kennedy SH
Curr Opin Psychiatry; 2007 Jul; 20(4):406-16. PubMed ID: 17551358
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators.
Vancampfort D; Vansteelandt K; Correll CU; Mitchell AJ; De Herdt A; Sienaert P; Probst M; De Hert M
Am J Psychiatry; 2013 Mar; 170(3):265-74. PubMed ID: 23361837
[TBL] [Abstract][Full Text] [Related]
17. The comorbidity of bipolar disorder and cardiovascular diseases from pharmacotherapy perspective.
Vuksan-Cusa B; Marcinko D; Sagud M; Jakovljević M
Psychiatr Danub; 2009 Sep; 21(3):382-5. PubMed ID: 19794361
[TBL] [Abstract][Full Text] [Related]
18. Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.
Keltner NL
Perspect Psychiatr Care; 2006 Aug; 42(3):204-7. PubMed ID: 16916424
[No Abstract] [Full Text] [Related]
19. Weight gain and metabolic issues of medicines used for bipolar disorder.
Fagiolini A; Chengappa KN
Curr Psychiatry Rep; 2007 Dec; 9(6):521-8. PubMed ID: 18221634
[TBL] [Abstract][Full Text] [Related]
20. Medical monitoring in patients with bipolar disorder: a review of data.
Fagiolini A
J Clin Psychiatry; 2008 Jun; 69(6):e16. PubMed ID: 18683991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
